“With the increased investments in our transplantation business that we have previously communicated, we see this spin-off as a natural next step. Our two business areas, Fertility and Transplantation, are in different phases of development and we on the Board consider that separate ownership increases the strategic opportunities that each company can utilize for increased added value," says the Chairman of the Board, Patrik Tigerschiöld.
Source and more information: www.vitrolife.com
Vacant positions within the biotech and life science area in the Göteborg region.
Here you find a list of current calls for proposals and applications for Life Science!